NO311921B1 - Anvendelse av preparat for behandling av hårtap - Google Patents
Anvendelse av preparat for behandling av hårtap Download PDFInfo
- Publication number
- NO311921B1 NO311921B1 NO19950925A NO950925A NO311921B1 NO 311921 B1 NO311921 B1 NO 311921B1 NO 19950925 A NO19950925 A NO 19950925A NO 950925 A NO950925 A NO 950925A NO 311921 B1 NO311921 B1 NO 311921B1
- Authority
- NO
- Norway
- Prior art keywords
- hair
- treatment
- hair loss
- tretinoin
- hydrocortisone
- Prior art date
Links
- 201000004384 Alopecia Diseases 0.000 title claims abstract description 35
- 230000003676 hair loss Effects 0.000 title claims abstract description 30
- 208000024963 hair loss Diseases 0.000 title claims abstract description 29
- 238000011282 treatment Methods 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims description 16
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims abstract description 38
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims abstract description 22
- 229960001727 tretinoin Drugs 0.000 claims abstract description 21
- 229960000890 hydrocortisone Drugs 0.000 claims abstract description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical group CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
- 239000003246 corticosteroid Substances 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 229930003231 vitamin Natural products 0.000 abstract description 5
- 235000013343 vitamin Nutrition 0.000 abstract description 5
- 239000011782 vitamin Substances 0.000 abstract description 5
- 229940088594 vitamin Drugs 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 210000004209 hair Anatomy 0.000 description 24
- 210000003780 hair follicle Anatomy 0.000 description 13
- 230000003779 hair growth Effects 0.000 description 12
- 210000004761 scalp Anatomy 0.000 description 11
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- 239000002453 shampoo Substances 0.000 description 6
- 208000002720 Malnutrition Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000018343 nutrient deficiency Nutrition 0.000 description 5
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 4
- 231100000360 alopecia Toxicity 0.000 description 4
- 230000003698 anagen phase Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000003054 hormonal effect Effects 0.000 description 4
- 229960003632 minoxidil Drugs 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000003797 telogen phase Effects 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 235000002566 Capsicum Nutrition 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- 241000722363 Piper Species 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 229940042129 topical gel Drugs 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 206010068168 androgenetic alopecia Diseases 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229960001102 betamethasone dipropionate Drugs 0.000 description 1
- CIWBQSYVNNPZIQ-XYWKZLDCSA-N betamethasone dipropionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CIWBQSYVNNPZIQ-XYWKZLDCSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 231100000573 exposure to toxins Toxicity 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229940125379 topical corticosteroid Drugs 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Steroid Compounds (AREA)
- Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94385392A | 1992-09-11 | 1992-09-11 | |
| PCT/US1993/008575 WO1994006434A1 (fr) | 1992-09-11 | 1993-09-13 | Procede et composition utiles pour traiter la chute des cheveux |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO950925D0 NO950925D0 (no) | 1995-03-10 |
| NO950925L NO950925L (no) | 1995-05-09 |
| NO311921B1 true NO311921B1 (no) | 2002-02-18 |
Family
ID=25480381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19950925A NO311921B1 (no) | 1992-09-11 | 1995-03-10 | Anvendelse av preparat for behandling av hårtap |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0659080B1 (fr) |
| JP (1) | JPH08501552A (fr) |
| AT (1) | ATE202935T1 (fr) |
| AU (1) | AU684470B2 (fr) |
| CA (1) | CA2144416C (fr) |
| DE (1) | DE69330429T2 (fr) |
| DK (1) | DK0659080T3 (fr) |
| ES (1) | ES2159294T3 (fr) |
| FI (1) | FI951126A (fr) |
| GR (1) | GR3036827T3 (fr) |
| NO (1) | NO311921B1 (fr) |
| NZ (1) | NZ256271A (fr) |
| PT (1) | PT659080E (fr) |
| WO (1) | WO1994006434A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6344448B1 (en) * | 1992-09-11 | 2002-02-05 | Stb Family Limited Partnership | Composition for the treatment of hair loss |
| GB2302808A (en) * | 1995-07-04 | 1997-02-05 | Surtech Int Ltd | Propylene glycol with low potency corticosteroids for topical treatment of the scalp |
| JP2002322050A (ja) * | 2001-04-25 | 2002-11-08 | Kenji Uehara | 発毛剤 |
| US7326717B2 (en) | 2003-05-06 | 2008-02-05 | L'oreal | Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof |
| FR2929117B1 (fr) | 2008-03-28 | 2010-05-07 | Oreal | Utilisation de l'association du 2,4-diaminopyrimidine 3-n-oxyde et du madecassosside et/ou du terminoloside pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute |
| FR2929118B1 (fr) | 2008-03-28 | 2010-05-07 | Oreal | Utilisation de l'association de madecassoside et/ou de terminoloside et d'une arginine pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute |
| FR2949052B1 (fr) | 2009-08-13 | 2015-03-27 | Oreal | Procede de traitement cosmetique du cuir chevelu. |
| WO2011076721A1 (fr) | 2009-12-22 | 2011-06-30 | Deutsches Krebsforschungszentrum | Fluoroquinolones pour le traitement et/ou la prophylaxie de maladies inflammatoires |
| US9861645B2 (en) * | 2012-12-28 | 2018-01-09 | Rak Holdings Llc | Anti-itch scalp treatment compositions and combinations |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5019569A (en) * | 1986-11-03 | 1991-05-28 | Ortho Pharmaceutical Corporation | Reversal of glucocorticoid-induced skin atrophy |
| EP0625045A4 (fr) * | 1992-02-07 | 1995-01-18 | Albert M Kligman | Procedes de traitement de dermatoses inflammatoires. |
-
1993
- 1993-09-13 DK DK93921500T patent/DK0659080T3/da active
- 1993-09-13 WO PCT/US1993/008575 patent/WO1994006434A1/fr active IP Right Grant
- 1993-09-13 JP JP6508201A patent/JPH08501552A/ja active Pending
- 1993-09-13 ES ES93921500T patent/ES2159294T3/es not_active Expired - Lifetime
- 1993-09-13 AT AT93921500T patent/ATE202935T1/de not_active IP Right Cessation
- 1993-09-13 EP EP93921500A patent/EP0659080B1/fr not_active Expired - Lifetime
- 1993-09-13 AU AU48573/93A patent/AU684470B2/en not_active Ceased
- 1993-09-13 NZ NZ256271A patent/NZ256271A/en not_active IP Right Cessation
- 1993-09-13 CA CA002144416A patent/CA2144416C/fr not_active Expired - Fee Related
- 1993-09-13 DE DE69330429T patent/DE69330429T2/de not_active Expired - Fee Related
- 1993-09-13 PT PT93921500T patent/PT659080E/pt unknown
-
1995
- 1995-03-10 FI FI951126A patent/FI951126A/fi unknown
- 1995-03-10 NO NO19950925A patent/NO311921B1/no unknown
-
2001
- 2001-10-08 GR GR20010401688T patent/GR3036827T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0659080A4 (fr) | 1997-11-12 |
| NZ256271A (en) | 1997-03-24 |
| PT659080E (pt) | 2001-10-31 |
| FI951126A0 (fi) | 1995-03-10 |
| FI951126A (fi) | 1995-03-10 |
| EP0659080A1 (fr) | 1995-06-28 |
| AU4857393A (en) | 1994-04-12 |
| DE69330429D1 (de) | 2001-08-16 |
| CA2144416A1 (fr) | 1994-03-31 |
| EP0659080B1 (fr) | 2001-07-11 |
| AU684470B2 (en) | 1997-12-18 |
| DE69330429T2 (de) | 2002-05-16 |
| ATE202935T1 (de) | 2001-07-15 |
| DK0659080T3 (da) | 2001-09-17 |
| GR3036827T3 (en) | 2002-01-31 |
| NO950925D0 (no) | 1995-03-10 |
| JPH08501552A (ja) | 1996-02-20 |
| WO1994006434A1 (fr) | 1994-03-31 |
| ES2159294T3 (es) | 2001-10-01 |
| NO950925L (no) | 1995-05-09 |
| CA2144416C (fr) | 2003-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5629002A (en) | Cosmetic or pharmaceutic preparations for improving hair quaility and stimulating growth of the hair | |
| Sheikh et al. | A new topical formulation of minoxidil and finasteride improves hair growth in men with androgenetic alopecia | |
| CN106890100A (zh) | 用于预防脱发和促进毛发生长的局部施用的组合物 | |
| CN110302223B (zh) | 一种用于修复毛囊的育发液制剂及其制备方法 | |
| EP0771555B1 (fr) | Agent a application externeaux proprietes nutritives et protectrices | |
| NO311921B1 (no) | Anvendelse av preparat for behandling av hårtap | |
| US9408857B2 (en) | Medicinal cosmetic lipoatrophy | |
| JP2000038340A (ja) | 育毛剤および食品 | |
| US6344448B1 (en) | Composition for the treatment of hair loss | |
| US4272508A (en) | Cosmetics for treatment of hair and skin | |
| US10213441B2 (en) | Medicinal cosmetic lipoatrophy | |
| CN112043627B (zh) | 一种毛发生长的氨基酸溶液组合物及其制备方法 | |
| DE69110861T2 (de) | Mittel zur verbesserung des kollagenmetabolismus und dessen verwendung. | |
| CN114366687B (zh) | 齐酞酸在促进毛发生长中的应用 | |
| JPH11302133A (ja) | 頭皮頭髪用化粧料 | |
| RU2732295C1 (ru) | Препарат для укрепления и стимулирования роста волос и способ его использования | |
| JPH0112725B2 (fr) | ||
| US20240269240A1 (en) | Compositions and methods for treating hair loss or facilitating hair growth | |
| Zerzevatcı et al. | Exploring Alopecia Areata: Clinical Variations, Hair Follicle Dynamics, and Treatment Perspectives | |
| KR20240040151A (ko) | 바이오틴 유도체 및 이를 함유하는 탈모 예방, 치료용 또는 개선용 조성물 | |
| JPH08208446A (ja) | 養毛剤及び毛髪用化粧料 | |
| CN112494488A (zh) | 瑞巴派特的防脱发和生发用途 | |
| Broulik et al. | Minoxidil does not possess androgenic activity | |
| JPH01199905A (ja) | 養毛化粧料 | |
| JPH11349449A (ja) | 頭皮頭髪用化粧料 |